Shenzhen Aimingen Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen Aimingen Technology Co., Ltd. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 27 (Floor Coverings) — 6 filings in this category. The portfolio also extends into Class 24 (Fabrics) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include LEATTIE, MISIFFA, STARUIA, TIVENEY, and MOESPACE. The owner is based in Shenzhen, Guangdong.
Rm. 3-318, Bldg. C5, Zhonghao Industrial
Shenzhen, Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Aimingen Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Shenzhen Aimingen Technology Co., Ltd. have?
Shenzhen Aimingen Technology Co., Ltd. has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does Shenzhen Aimingen Technology Co., Ltd. file in?
Shenzhen Aimingen Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 27 (Floor Coverings), Class 24 (Fabrics). Class 27 covers carpets, rugs, mats and matting, linoleum and other materials for covering floors.
What are Shenzhen Aimingen Technology Co., Ltd.'s most well-known trademarks?
Shenzhen Aimingen Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as LEATTIE, MISIFFA, STARUIA, TIVENEY, and MOESPACE. These are among 7 currently registered trademarks in the portfolio.
What is Shenzhen Aimingen Technology Co., Ltd.'s trademark registration success rate?
Shenzhen Aimingen Technology Co., Ltd. has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.